Here’s a nice piece of news. My periodic updates on active PSP neuroprotection treatment trials have mentioned a drug called TPN-101.  That’s an oral drug that inhibits an enzyme called reverse transcriptase.  If that term sounds familiar, it’s because that’s one of the mechanisms of anti-HIV drugs.  Transposon Therapeutics issued a press release yesterday announcing … Continue reading Putting the cat back into the bag